Molecular Remission One Year Following Reduced-Intensity Allogeneic Hematopoietic Cell Transplantation for Chronic Lymphocytic Leukemia Predicts Relapse-Free and Overall Survival: A Multi-Institutional Landmark Analysis Logan, A. C., Herrera, A. F., Ryan, C. E., Rezvani, A. R., Kong, K. A., Faham, M., Alatrash, G., Molldrem, J. J., Sargent, R. L., Alyea, E. P., Ho, V. T., Brown, J. R., Ritz, J., Miklos, D. B. AMER SOC HEMATOLOGY. 2015

View details for Web of Science ID 000368021801282